This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

LNPs Europe
3-5 November 2026
Hotel Palace BerlinBerlin, Germany
Book Now
Menu
Book
Key Sessions
Gonzalo Fernández-Miranda
Enabling LNP-DNA Delivery to Target Peripheral Nerve Diseases
CureAge Therapeutics
Matthias Bozza
Targeted Lipid Nanoparticles Deliver Immune-Silent ssDNA to Generate CAR T Cells
CPTx
keyboard_arrow_right

Thursday 5th November 2026 – Main Agenda - Day Two

search
Thursday 5th November 2026 – Main Agenda - Day Two
search
Showing 1 of 1 Streams
08:30 - 09:00
Registration & Morning Coffee
Showing 1 of 1 Streams
09:00 - 09:10
Welcome to LNPs Europe – Chairperson’s Welcome
09:10 - 09:40
Bridging Viral and Lipid Nanoparticle Worlds: Surface Engineering Lentiviral Vector-Based Nanoparticles for Targeted In Situ CAR-T Cell Therapy
  • Céline Jaudouin - Senior Formulation Scientist, Alaya.bio
09:40 - 10:10
Panel Discussion: Scale-Up Strategies: Navigating the Road Ahead for In Vivo CAR-T
  • Lorenz Mayr - Managing Director, BioMedTech Consulting GmbH
  • Matthias Bozza - Director, Head of Strategy and R&D, CPTx
10:10 - 10:40
Sponsored Scientific Track Presentation

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.

To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

Showing 2 of 2 Streams
10:40 - 11:20
Morning Coffee and Networking Break in Exhibition Hall
10:40 - 11:20
Poster Viewing - Meet the Poster Presenters

Explore groundbreaking research, meet the poster presenters and ask your questions.

Showing 1 of 1 Streams
11:20 - 11:50
Enabling LNP-DNA Delivery to Target Peripheral Nerve Diseases
  • Gonzalo Fernández-Miranda - CEO and Co-Founder, CureAge Therapeutics
11:50 - 12:20
Targeted Lipid Nanoparticles Deliver Immune-Silent ssDNA to Generate CAR T Cells
  • Matthias Bozza - Director, Head of Strategy and R&D, CPTx
12:20 - 12:50
Sponsored Scientific Track Presentation: Designing Novel Chemistries and Novel Lipids to Overcome Bottlenecks - Endosomal Escape, Decrease Toxicity and Dosage Requirements

This session is your platform to demonstrate leadership and technical expertise. Present your data, case studies, and innovative solutions to a targeted audience of senior scientists and engineers looking to solve hurdles in their production processes.To learn more about sponsoring this session, contact us at Partners@informaconnectls.com

Showing 1 of 1 Streams
12:50 - 14:00
Networking Lunch in the Exhibition Hall
Showing 1 of 1 Streams
14:00 - 14:30
R&D Innovations: Case Studies Next-Generation Therapeutic Applications of LNPs
  • Katia Lemdani - Director Research and Development, Neovacs
14:30 - 15:00
Engineering LNPs for Next Generation Vaccines & Therapeutics
  • Heinrich Haas - Chief Technology Officer, NeoVac
15:00 - 15:30
R&D Innovations: Case Studies Next-Generation Therapeutic Applications of LNPs
Showing 1 of 1 Streams
15:30 - 16:00
Afternoon Coffee and Networking Break in Exhibition & Poster Hall
Showing 1 of 1 Streams
16:00 - 16:30
Application of AI and Machine Learning in LNP Development
16:30 - 17:00
Advances in Stability Storage and Formulation Innovations for LNPs
17:00 - 17:05
Close of Event 2026 – See You Next Year!
Wednesday 4th November 2026 – Main Agenda - Day One
Choose Day